Cargando…

Safety evaluation of early drain removal following pancreaticoduodenectomy: A single-center retrospective cohort study

OBJECTIVES: The effects of early drain removal (EDR) on postoperative complications after pancreaticoduodenectomy (PD) remains to be investigated. This single-center retrospective cohort study was designed to explore the safety of EDR after PD. METHODS: A total of 112 patients undergoing PD with dra...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xuehai, Chen, Kai, Liu, Zonghao, Wang, Feng, Ma, Yongsu, Zhang, Shupeng, Shao, Zhijiang, Yang, Yinmo, Tian, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554647/
https://www.ncbi.nlm.nih.gov/pubmed/36249020
http://dx.doi.org/10.3389/fonc.2022.993901
Descripción
Sumario:OBJECTIVES: The effects of early drain removal (EDR) on postoperative complications after pancreaticoduodenectomy (PD) remains to be investigated. This single-center retrospective cohort study was designed to explore the safety of EDR after PD. METHODS: A total of 112 patients undergoing PD with drain fluid amylase (DFA) on postoperative day (POD) 1 and 3 <= 5000 were divided into EDR and late drain removal (LDR). Propensity Score Matching (PSM) was used. We compared postoperative outcomes between two groups and explore the risk factors of total complications using univariate and multiple logistic regression analyses. RESULTS: No statistical differences were found in primary outcomes, including Grade B/C postoperative pancreatic fistula (POPF) (Original cohort: 5.71% vs. 3.90%; P = 1.000; PSM cohort: 3.33% vs. 6.67%; P = 1.000), and total complications (Original cohort: 17.14% vs. 32.47%; P = 0.093; PSM cohort: 13.33% vs. 33.33%; P = 0.067). The EDR was associated with shorter in-hospital stay (Original cohort: 11 days vs. 15 days; P < 0.0001; PSM cohort: 11 days vs. 15 days; P < 0.0001). CONCLUSIONS: EDR on POD 3 is safe for patients undergoing PD with low risk of POPF.